Development and validation of LC–MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider

作者
Yuchen Sun,Kosuke Saito,Shin-ichiro Nitta,Ryoya Goda,Yuki Kishino,Hisashi Fujita,Masaaki Kakehi,Yoshiharu Hayashi,Satoshi Ito,Tomomi Ishida,Kiyomi Kikuchi,Kazuko Inoue,Kazutaka Shimbo,Takeru Yamaguchi,Fumihiro Jinno,Kaori Murakoshi,Chie Murata,Kentaro Takahara,Mitsuhiko Kawabata,Ruri Kikura‐Hanajiri
出处
期刊:Drug Metabolism and Pharmacokinetics [Elsevier BV]
卷期号:70: 101545-101545
标识
DOI:10.1016/j.dmpk.2026.101545
摘要

The analysis of oligonucleotide therapeutics, including antisense oligonucleotides and siRNAs, using existing bioanalytical methods presents unique analytical challenges owing to their distinctive physicochemical properties. Although the ICH M10 guideline provides general bioanalytical validation frameworks, specific considerations for oligonucleotide therapeutics remain undefined, highlighting an urgent need for targeted points to be considered. This white paper presents comprehensive recommendations developed through expert consensus and a literature review by the Japan Agency for Medical Research and Development research groups, addressing the critical technical challenges in liquid chromatography-mass spectrometry (LC-MS)-based bioanalytical methods for oligonucleotide therapeutics. It focuses on ion-pair reversed-phase LC-MS methodologies and emerging techniques, such as hybridization extraction, addressing key issues, including mobile phase stability and degradation, metal adsorption mitigation, carryover prevention, internal standard selection, and matrix effects unique to nucleic acids. The comprehensive coverage includes sample preparation strategies, chromatographic optimization, mass spectrometric detection approaches, and validation parameters adapted from ICH M10, with fit-for-purpose modifications on a case-by-case basis when conventional acceptance criteria cannot be applied. This white paper provides practical recommendations for the development and validation of analytical methods specific to oligonucleotide therapeutics, supports regulatory submissions, and promotes the international harmonization of bioanalytical standards in this rapidly expanding therapeutic modality.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
信徒完成签到,获得积分10
1秒前
慕青的应助被正直的的白羊采纳,获得10
1秒前
四福祥完成签到,获得积分10
1秒前
ace完成签到,获得积分10
1秒前
weixiaozhe完成签到,获得积分10
1秒前
好学天上完成签到,获得积分10
1秒前
韶芸遥完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
药药55完成签到,获得积分10
2秒前
Delia完成签到 ,获得积分10
2秒前
腾腾完成签到 ,获得积分10
2秒前
珊珊发布了新的文献求助10
2秒前
kkkkkk完成签到,获得积分10
2秒前
谨慎的映雁完成签到,获得积分10
3秒前
12321完成签到,获得积分10
3秒前
浣熊完成签到 ,获得积分10
3秒前
HPP123完成签到 ,获得积分10
3秒前
凶狠的璎完成签到,获得积分10
4秒前
4秒前
Jenny完成签到,获得积分10
4秒前
英俊的铭的应助被rtf采纳,获得10
4秒前
静静的旋律完成签到 ,获得积分10
5秒前
6秒前
白夜完成签到 ,获得积分10
6秒前
6秒前
Tokgo完成签到,获得积分10
7秒前
stone发布了新的文献求助10
7秒前
风吹麦浪的应助被a_mo采纳,获得10
7秒前
cube完成签到,获得积分10
7秒前
威武的海棠花完成签到,获得积分10
7秒前
整齐惋庭完成签到,获得积分10
7秒前
luyue9406的应助被xzn1123采纳,获得10
8秒前
Science完成签到,获得积分10
8秒前
糊涂涂完成签到,获得积分10
9秒前
啦啦啦完成签到,获得积分20
9秒前
jwy完成签到,获得积分10
9秒前
侯侯完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159288
求助须知:如何正确求助?哪些是违规求助? 9554702
关于积分的说明 21720900
捐赠科研通 7748911
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552111
邀请新用户注册赠送积分活动 2471479